Establishing a trusted lab partner in an evolving landscape

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support of a business partner like Mayo Clinic Laboratories.

Dr. Morice acknowledges that the U.S. Food and Drug Administration’s (FDA) final rule on regulating laboratory-developed tests as medical devices will impact the future of many laboratories. Hospital administrators will face challenging decisions while continuing to balance rising healthcare costs with high-quality services. The good news, he says, is that hospital labs have navigated inflection points before, like responding to the COVID-19 pandemic, and those lessons can be applied to this shifting landscape.

“Now we face new headwinds, but we can use these insights and experiences to plot a path forward,” says Dr. Morice. “While hospital leaders may look at this new regulatory environment as another nearly insurmountable obstacle and further reason to divest lab ownership, Mayo Clinic Laboratories challenges you to stay the course. And if you’re in need of a partner who is focused on high-quality testing services backed by real-life clinical care, you can turn to us.”

Read the full article on Becker’s Hospital Review.